Edgewise Therapeutics Inc (EWTX)

Edgewise Therapeutics Inc (EWTX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $4.3B; returns 1 day -1.7%, 1 week +5.7%, 1 year +160.3%.

Edgewise Therapeutics, Inc. (EWTX) is a clinical-stage biopharmaceutical company focused on developing precision medicines for muscle diseases, including rare muscular dystrophies and cardiac conditions like hypertrophic cardiomyopathy (HCM).

Groups EWTX belongs to

• Biopharmaceutical
• Clinical Stage Biopharma
• Rare Diseases
• Healthcare
• Biotechnology
• Clinical Stage Biotech
• Precision Medicine
• Cardiovascular Therapies
• Duchenne Muscular Dystrophy
• Clinical Stage
• R&D

EWTX financial model: income statement, cash flow and balance sheet